The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / SLE Patients May Not Receive Enough Cardiovascular Disease Assessment & Treatment

SLE Patients May Not Receive Enough Cardiovascular Disease Assessment & Treatment

January 2, 2019 • By Arthritis Care & Research

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Systemic lupus erythematosus (SLE) is associated with high rates of atherosclerotic cardiovascular disease (CVD), and recent research has shown SLE patients may have a higher risk of CVD than patients with diabetes mellitus. Diabetes mellitus is considered an independent CVD risk factor, and as such aggressive risk assessment with lipid screenings and treatment with statins are used to decrease patient morbidity and mortality.

You Might Also Like
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
  • Insight into Endothelial Dysfunction in Early SLE Patients without Cardiovascular Disease

Some have advocated for this aggressive management of CVD risk with annual assessments in SLE patients. However, studies have shown that provisions of care based on these recommendations may be suboptimal. New research from Sarah K. Chen, MD, and colleagues from Brigham and Women’s Hospital, Boston, sheds light on the use of aggressive CVD management in SLE patients.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Using patient information from Medicaid Analytic extract, the study examined the rates of lipid testing and dispensing of prescriptions for statins in SLE patients and compared them to patients with diabetes mellitus and Medicaid recipients who had neither disease. Each SLE patient was matched for age and sex with two patients with diabetes mellitus and four people in the general Medicaid population. The cohorts comprised 25,950 SLE patients, 51,900 diabetes mellitus patients and 103,800 Medicaid recipients.

Researchers then used multivariable logistic regression to calculate the odds of lipid testing and treatment with statins and conditional logistic regression to compare the cohorts. The findings were published in January Arthritis Care & Research.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The Results
“Despite having an elevated risk of CVD, SLE patients received less lipid testing and received fewer statin prescriptions compared with age-and sex-matched diabetes mellitus patients and individuals in the general Medicaid population,” write the authors.

Researchers found SLE patients in this large Medcaid cohort had more prevalent CVD at baseline compared with age-and sex-matched patients with diabetes mellitus. And, despite recommendations for annual CVD risk assessment, only 24% of Medicaid beneficiaries with SLE in this study received lipid testing during 1-year follow-up. Only 11% of these SLE patients received statin prescriptions.

Additionally, SLE patients were 66% less likely to have lipid testing and 82% less likely to receive a statin prescription during 1-year follow-up. SLE patients were also less likely to fill a statin prescription compared with individuals in the general Medicaid population with neither disease.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The authors conclude, “Care for the prevention of CVD in SLE patients receiving Medicaid is not consistently provided, and efforts should be made to establish and disseminate clear evidence-based guidelines to improve care and outcomes in this high-risk population.”

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Arthritis Care & Research

You Might Also Like:
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities
  • Newly Diagnosed SLE Patients Have a Greater Risk of Cardiovascular Disease
  • Insight into Endothelial Dysfunction in Early SLE Patients without Cardiovascular Disease
  • Researcher Studies Ways to Cut Cardiovascular Disease Risk in Rheumatoid Arthritis Patients

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.